Event Sponsors:
 

Agilent Technologies India Pvt. Ltd., India
 

Synchron Research Services Pvt. Ltd., India
 

Novartis, USA
 

GSB Life Sciences, USA
 

Cetero Research, USA
 

Pharmaceutics International, Inc, USA
 
 
 
 

Scientific Programme
Track Information
Track 6: PK/PD and Drug Discovery

Opening Ceremony
8:00 - 8:10
 Group Photo/Prayer
8:20 - 8:30
Chair's Opening Remark
8:30 - 9:00
 VIP's Address
Keynote Forum
9:00 - 9:25
Title: Challenges in BE Requirements for Certain Class / Types of Drug Products
Dr. Vinod P. Shah, Pharmaceutical Consultant, Documentary Standards Division,
US Pharmacopeia, 12601 Twinbrook Parkway, Rockville, MD, USA.
9:25 -9:50
Title: Scientific and Regulatory Challenges of Bioavailability/Bioequivalence in the 21st Century
Dr. Mansoor A. Khan,
Director, Division of Product Quality Research, FDA/CDER/OPS/OTR,
White Oak, LS Building 64, Room 1070, 10903 New Hampshire Ave,
Silver Spring, MD, USA.
9:50 - 10:15
Title: Anti-angiogenesis Therapy: Past, Present and Future
Prof. Debabrata Mukhopadhyay,
Department of Biochemistry and Molecular Biology,
Mayo Clinic School of Medicine, Guggenheim 1401A,
200 First Street Southwest, Rochester, MN 55905, USA.
10:15 - 10:25
Coffee Break
10: 25 - 10:50
Title: Critical Pathway Initiative of Generic Drug Development
Dr. Shivprakash Rathnam, Managing Director,
Synchron Research Services Pvt. Ltd., Ahmadabad, India.
10:50 - 11:15
Title: Optimizing Systemic Exposure in Preclinical Species and Humans: Practical Strategies and Learnings for Discovery and Development
Dr. Tycho Heimbach,
Novartis Institutes for BioMedical Research,
DMPK - Translational Sciences (TS), USEH, 436/3253,
One Health Plaza, East Hanover, NJ 07936-1080, USA.
11:15 - 11:40
Title: Challenges Encounterd in the Conduction of Bioequivalence Studies of Some Drug Products
Dr. Naji M. Najib,
Professor of Pharmaceutics,
Chairman, International Pharmaceutical Research Center (IPRC),
1 Queen Rania Street - Sport City Circle,
P.O. Box 963166, Amman 11196, Jordan.
11:40 - 12:05
Title: On Modeling Methods and Predictability of In-Vitro-In-Vivo Correlation (IVIVC)
of Oral Controlled Release Products
Dr. Bhaswat S. Chakraborty, Sr. Vice President, R&D, Cadila Pharmaceuticals, India.

Sponsor/
Partial supporter/
Co-organizer

Track Infomation
Track 1: Practical Solutions to Pharmaceutical Bioequivalence/Bioavailability Implementation


Food and Drug Administration, USA


Aurobindo Pharma Ltd., India


Rhodes University,
South Africa


University of Notre Dame, USA


Faculty of Medicine Siriraj Mahidol University, Thiland


 

 Time  Track
March 1, 2010
 (Monday)
  13:00-18:00		 Track 1-1: Bioequivalence Strategies in Development-an Industry Perspective
Session Chair: Dr. Sam H. Haidar, Lead Pharmacologist,
Office of Generic Drugs, Food and Drug Administration, Rockville, Maryland, USA.
Session Co-Chair: Dr. A.T. Bapuji,
Vice president, Clinical Pharmacology Department,
APL Research Centre, Aurobindo Pharma Ltd.,
Hyderabad, India.
13:00-13:05 Session Introduction
13:05-13:30 Title: Recent Advances in the Evaluation of Bioequivalence
Dr. Sam H. Haidar, Lead Pharmacologist,
Office of Generic Drugs, Food and Drug Administration,
Rockville, Maryland, USA.
13:30-13:55 Title: Bioequivalence Testing - Industry Prespective
Dr. A.T. Bapuji,
Vice president, Clinical Pharmacology Department,
APL Research Centre, Aurobindo Pharma Ltd.,
Hyderabad, India.
13:55-14:20 Title: Current Strategies for the Bioequivalence Assessment of Topical Dermatological Dosage Forms
Dr. Isadore Kanfer, Emeritus Professor, Faculty of Pharmacy,
Rhodes University, Grahamstown, South Africa.
14:20-14:45 Title: Quick Assay of Pathogenic Bacteria in Kidney Infection using Gold Nano-Biosensors
Dr. Subhash C. Basu, University of Notre Dame, Notre Dame, Indiana 46556, Department of Chemistry and Biochemistry, USA.
14:45-16:20 Coffee Break & Poster Session 
16:20-16:45

Title: TBD
Dr. Ethan M. Stier, R.Ph., PhD, Division of Bioequivalence II,
Office of Generic Drugs,
Food and Drug Administration Rockville, MD 20855, USA.
16:45-17:10 Title: The Situation of Bioequivalence Studies in Thailand: Past, Present, and Future
Dr. Supornchai Kongpatanakul, MD, Head,
Department of Pharmacology and Siriraj Bioequivalence Center,
Faculty of Medicine Siriraj Mahidol University, Bangkok, Thailand.
17:10-17:35 Title: Challenges of Bioequivalence Studies in the Middle East
Dr. Maha Tutunji
17:35-18:00 Panel Discussion


Dr. Reddy's Laboratories, India


Abbott Laboratories, USA


Universiti Sains Malaysia, Malaysia


Al-Ameen College of Pharmacy, India


University of Canberra, Australia


 

 
March 1, 2010
 (Monday)
 13:00-18:00		 Track 1-2: Comparative Bioavailability Studies for  New Drugs  (NDA)
Session Chair: Dr. V. Venkateswarlu, Dr. Reddy's Laboratories, India.
Session Co-Chair: Dr. Rajendra S Pradhan,
Director, Clinical Pharmacokinetics and Pharmacodynamics,
Clinical Pharmacology and Pharmacometrics, Abbott labs,
Abbott Park, IL, USA.
13:00-13:05 Session Introduction
13:05-13:30 Title: Challenges in Conducting BA/BE Assessments During Clinical Development of Oncology Drugs
Dr. Rajendra S Pradhan,
Director, Clinical Pharmacokinetics and Pharmacodynamics,
Clinical Pharmacology and Pharmacometrics, Abbott labs,
Abbott Park, IL, USA.
13:30-13:55 Title: TBD
Dr. V. Venkateswarlu, Dr. Reddy's Laboratories, India.
13:55-14:20 Title: Evaluating Effect of Self-Microemulsifying Drug Delivery Formulation and Concomitant Administration of Piperine on Bioavailability of Sulpiride, a P-gp Substrate and BCS Class IV Drug
Dr. Peh Kok Khiang, School of Pharmaceutical Sciences,
Universiti Sains Malaysia, 11800 Penang, Malaysia.
14:20-14:45 Title: In-Vitro and In-Vivo Evaluation of Microprocessor Controlled Iontophoretic Transdermal Drug Delivery of Anti-Cancer Drugs
Dr. Chandrashekar NS, Al-Ameen College of Pharmacy,
Near Lalbagh Main Gate, Hosur Road,
Bangalore-560027, India.
14:45-16:20 Coffee Break & Poster Session 
16:20-16:45 Title: Bioequivalence in Trans dermals
Dr. Charu Gautam, Director- Clinical Operations,
BA Research India Ltd, Ahmedabad, India.
16:45-17:10 Title: TBD
Dr. Rachel W. Li,
Trauma and Orthopaedic Research Laboratory,
The Australian National University Medical School,
University of Canberra, Division of Immunology and Genetics,
JCSMR, Australia.
17:10-17:35 Speech Opportunity Available
17:35-18:00 Panel Discussion


Synchron Research Services Pvt. Ltd., India


University of Hyderabad,
India


Karnataka State Open University, India


Cipla Ltd., India


Noida Institute of Engg & Tech, India


Texas Tech School of Pharmacy , USA

March 1, 2010
 (Monday)
13:00-18:00		 Track 1-3: Comparative Bioavailability Generic Drug Products (ANDA): Bioequivalence Studies
Session Chair: Dr. Shivprakash Rathnam, Managing Director,
Synchron Research Services Pvt. Ltd., Ahmadabad, India.
Session Co-Chair: Dr. Ashwini Nangia, School of Chemistry,
University of Hyderabad, Hyderabad 500 046, India.
13:00-13:05 Session Introduction
13:05-13:30 Speech Opportunity Available
13:30-13:55

Title: Pharmaceutical Cocrystals to Modify Physico-Chemical and Dissolution Profile of APIs
Dr. Ashwini Nangia, School of Chemistry,
University of Hyderabad, Hyderabad 500 046, India.
13:55-14:20

Title: Synthesis of Novel Heterocyclic Compounds for Induction of Apoptosis in Human Leukemia Cells
Prof. K.S. Rangappa, Vice-Chancellor,
Karnataka State Open University(KSOU), Manasagangotri,
Mysore-570 006, India.
14:20-14:45 Title: Challenges in the Design of Comparative Bioavailability Studies – An Industry Perspective
Dr. Siddarth S. Chachad,
Medical & Safety Expert (Regulatory Affairs),
Cipla Ltd., India.
14:45-16:20 Coffee Break & Poster Session 
16:20-16:45 Title: Bioequivalence Strategies for Oncology Products
Dr. Shivprakash Rathnam, Managing Director,
Synchron Research Services Pvt. Ltd., Ahmadabad, India.
16:45-17:10 Title: Bioavailability and Bioequivalence Studies of Citric Acid and Malonic Acid Based Aspirin Effervescent Tablets
Dr. Sanjita Das,
Head, Department of Pharmaceutical Technology,
Noida Institute of Engg & Tech, Greater Noida, India.
17:10-17:35 Title: TBD
Dr. Fakhrul Ahsan, Department of Pharmaceutical Sciences,
Texas Tech School of Pharmacy, Amarillo, Texas, USA.
17:35-18:00 Panel Discussion

International Pharmaceutical Research Center, Jordan


University of Petra,
Jordan


Jadavpur University,
India
March 1, 2010
 (Monday)
13:00-18:00		  Track 1-4: Implementing BA/BE Guidelines and CRO Qualification Criteria
Session Chair: Dr. Naji M. Najib, Professor of Pharmaceutics,
Chairman, International Pharmaceutical Research Center (IPRC),
1 Queen Rania Street - Sport City Circle,
P.O. Box 963166, Amman 11196, Jordan.
Session Co-Chair: Dr. Nasir M. Idkaidek,
College of Pharmacy & Medical Sceinces,
University of Petra, Amman, Jordan.
13:00-13:05 Session Introduction
13:05-13:30

Title: Effect of Replicate Design on Drug Variability and Bioequivalence in Humans
Dr. Naji M. Najib, Professor of Pharmaceutics,
Chairman, International Pharmaceutical Research Center (IPRC),
1 Queen Rania Street - Sport City Circle,
P.O. Box 963166, Amman 11196, Jordan.
13:30-13:55 Title: Effect of Truncated AUC Method on Drug Bioequivalence in Humans: an EMEA Draft Guideline Evaluation
Dr. Nasir M. Idkaidek,
College of Pharmacy & Medical Sceinces,
University of Petra, Amman, Jordan.
13:55-14:20 Speech Opportunity Available
14:20-14:45 Speech Opportunity Available
14:45-16:20 Coffee Break & Poster Session
16:20-16:45 Title: Bioequivalence Study of Two FDC Formulations Containing Metformin, Glibenclamide and Pioglitazone in Healthy Indian Volunteers
Dr. Tapan Pal, Bioequivalence Study Centre,
Jadavpur University, Kolkata, India.
16:45-17:10 Title: TBD
Dr. Fotso Wabo Ghislain
17:10-17:35 Speech Opportunity Available
17:35-18:00 Panel Discussion
 
Welcome Banquet  : March 01, 2010 Call for sponsor!
 Time  18:15-20:00
Track Infomation
Track 2: Pharmacokinetic/Pharmacodynamic Models, Biowaivers and Biosimilars


University of Petra,
Jordan


University Hospital Zurich, Switzerland


B. V. Patel Perd Centre, India


Jamia Hamdard, India


National University of Singapore, Singapore


Ege University, Turkey
 Time  Track
March  2, 2010
 (Tuesday)
 8:30-12:00 		Track 2-1: Human/Animal Models in Oral Drug Absorption
Session Chair: Dr. Nasir M. Idkaidek,
College of Pharmacy & Medical Sceinces,
University of Petra, Amman, Jordan.
Session Co-Chair: Dr. Antoine Malek, University Hospital Zurich,
Department of Obstetrics, Research Division,
Frauenklinikstr. 10, 8091 Zurich, Switzerland.
8:30-8:35 Session Introduction
8:35-9:00

Title: Inter-individual Variability and Drug Development: BA/BE as Research Tool
Dr. Harish Padh, Director, B. V. Patel Perd Centre,
Thaltej-gandhinagar highway, Thaltej, Ahmedabad, India.
9:00-9:25 Title: Bioavailability Enhancement of Ropinirole by Using Nanoemulsion Based System
Dr. Sushama Talegaonkar, Department of Pharmaceutics,
Faculty of Pharmacy, Jamia Hamdard, New Delhi-110062, India.
9:25-9:50 Title: The Importance of the Human Placenta Ex Vivo Perfusion Model in the Drug Development for Human Pregnancy
Dr. Antoine Malek, University Hospital Zurich,
Department of Obstetrics, Research Division,
Frauenklinikstr. 10, 8091 Zurich, Switzerland.
9:50-10:15 Title: Enhancement of Oral Bioavailability of Insulin in Humans
Dr. Nasir M. Idkaidek,
College of Pharmacy & Medical Sceinces,
University of Petra, Amman, Jordan.
10:15-10:25 Coffee Break
10:25-10:50 Title: Drug Discovery from Natural Toxins and on Animal models
Dr. P.Gopalakrishnakone,
President, International Society on Toxinology,
Department of Anatomy & Venom and Toxin Research Programme, Yong Loo Lin School of Medicine,
National University of Singapore,
Lower Kent Ridge Road, Singapore.
10:50-11:15 Title: Human/Animal Models in Oral Drug Absorption
Dr. Ercument Karasulu, Assoc.Professor, Ege University,
Center for Drug R&D and Pharmacokinetic Applications,
35100 Bornova, IZMIR, Turkey.
11:15-11:40 Speech Opportunity Available
11:40-12:00 Panel Discussion


Renal Unit, UK


King Saud University,
Saudi Arabia


University Hospital Zurich, Switzerland


Hôpital Saint-Antoine, Paris


European Medicines Agency, UK


Alessandro Manzoni Hospital, Italy


Widener University, USA

 
March 2, 2010
(Tuesday)
13:00-18:00		 Track 2-2: Biosimilars and Biowaivers
Session Chair: Dr. David Goldsmith, Renal Unit, New Guy House, 
Guy's Hospital, London, UK.
Session Co-Chair: Dr. Khalid Alkharfy,College of Pharmacy,
King Saud University, Riyadh, Saudi Arabia.
13:00-13:05 Session Introduction
13:05-13:30 Title:  Biosimilar Products Selection: Challenges for Clinicians
Dr. Khalid Alkharfy,College of Pharmacy,
King Saud University, Riyadh, Saudi Arabia.
13:30-13:55

Title: Drug Delivery in Pregnancy: Transport of Nanoparticles Across the Human Placenta and Fetal Exposure
Dr. Antoine Malek, University Hospital Zurich,
Department of Obstetrics, Research Division,
Frauenklinikstr. 10, 8091 Zurich, Switzerland.
13:55-14:20

Title: European Regulations in the Context of Biosimilars
Dr. Jean-Louis Prugnaud, Chef de Service,
Hôpital Saint-Antoine, 184 rue du Fbg Saint-Antoine,
Paris.
14:20-14:45 Title: Biosimilars and CHMP EU Scientific Aadvice
Dr. Efthymios Manolis, Scientific Administrator,
Scientific Advice Human - Pre Authorisation Evaluation, EMEA,
7 Westferry Circus, Canary Wharf, London, UK.
14:45-16:20 Coffee Break & Poster Session
16:20-16:45 Title: Biosimilar of Epoetin Alfa: Issues on Comparability and Immumogenicity
Dr. Lucia Del Vecchio, 
Department of Nephrology and Dialysis,
A. Manzoni Hospital, Lecco, Italy.
16:45-17:10 Title: Biosimilars and Follow-on Biologics
Dr. Fuhr Joseph P, Widener University, One University Place, Chester, PA 19013, USA.
17:10-17:35 Title: Biosimilar Epoetins in Europe - A Success Story?
Dr. David Goldsmith, Renal Unit, New Guy House,
Guy's Hospital, London, UK.
17:35-18:00 Panel Discussion


GSB Life Sciences, USA


Stanford University School of Medicine, USA


Cairo University, Egypt


Lord Shiva College of Pharmacy, India


Kazusa DNA Research Institute, Japan


University of Edinburgh, UK


University at Buffalo, USA
March 2, 2010
 (Tuesday)
 8:30-12:00 		Track 2-3: Biosimulation in BE Studies-Prediction Tools
Session Chair: Dr. Srinubabu Gedela,
Stanford University School of Medicine, USA.
Session Co-Chair: Prof. Hany A. El-Shemy, Director of Biotechnology Labs,
FARP, Biochemistry and Molecular Biology,
Biochemistry Department, Faculty of Agriculture,
Cairo University, 12613 Giza, Egypt.
8:30-8:35 Session Introduction
8:35-9:00 Speech Opportunity Available
9:00-9:25

Title: In-Silico Selection of Natural Anti-leukaemia Compounds
Prof. Hany A. El-Shemy, Director of Biotechnology Labs,
FARP, Biochemistry and Molecular Biology,
Biochemistry Department, Faculty of Agriculture,
Cairo University, 12613 Giza, Egypt.
9:25-9:50 Title: In Silico Adme Prediction Using QSPR Studies
Dr. Yash Paul Singla,
Principal, Lord Shiva College of Pharmacy,
P.B. No.63, Near Civil Hospital, Sirsa-125055, Haryana, India.
9:50-10:15 Title: TBD
 Dr. Hsin-Yun HSU, Laboratory of Medical Genomics,
Department of Human Genome Research,
Kazusa DNA Research Institute, Kisarazu, Chiba, Japan.
10:15-10:25 Coffee Break
10:25-10:50 Title: TBD
 Dr. Alexey Goltsov, Centre for Systems Biology of Edinburgh,
School of Biological Sciences, University of Edinburgh,
The Kings Buildings, Mayfield Road, Edinburgh, EH9 3JU, UK.
10:50-11:15 Title: Drug Delivery System for Proteins and Biosimilars
Dr. Sathy V. Balu-Iyer, Associate Professor,
Department of Pharmaceutical Sciences, 521 Hochstetter Hall,
University at Buffalo, State University of New York,
Amherst, New York, USA.
11:15-11:40 Speech Opportunity Available
11:40-12:00 Panel Discussion


Chungnam National University, Korea


Eli Lilly and Company, USA


Synchron Research Services Pvt. Ltd., India

March 2, 2010
 (Tuesday)
13:00-18:00		 Track 2-4: Statistical Issues in BA/BE
Session Chair: Prof. Kwang-il Kwon, College of Pharmacy,
Chungnam National University, Daejeon, Korea.
Session Co-Chair: Ms. Ying Grace Li, Project Statistician
Statistics-AI/ MSK/ CC/ CV, Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285, USA.
13:00-13:05 Session Introduction
13:05-13:30 Title: Bioequivalence Methods for Assessment of Highly
Variable Drug – ABE, SABE, PBE and IBE
Prof. Kwang-il Kwon, College of Pharmacy,
Chungnam National University, Daejeon, Korea.
13:30-13:55 Speech Opportunity Available
13:55-14:20 Title: The Application of Bayesian/Frequentist Analysis in Bioequivalence/Bioavailability Studies
Ms. Ying Grace Li, Project Statistician,
Statistics-AI/ MSK/ CC/ CV, Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285, USA.
14:20-14:45 Speech Opportunity Available
14:45-16:20 Coffee Break & Poster Session
16:20-16:45 Title: Sparse Sampling Strategies in Pharmacokinetics and Bioequivalence
Dr. Shubha Rani,
Technical Director & Head - Biometrics and Data Management,
Synchron Research Services Pvt. Ltd.,
'The chambers', 3rd Floor, Bodakdev, SG Highway,
Ahmedabad, India.
16:45-17:10 Speech Opportunity Available
17:10-17:35 Speech Opportunity Available
17:35-18:00 Panel Discussion


Rhodes University,
South Africa


Harvard Medical School, USA


Cadila Pharmaceuticals Limited, India


University of Trieste, Italy


University of Hyderabad,
India

 
March 2, 2010
 (Tuesday)
 8:30-12:00 		Track 2-5: In Vivo/In Vitro Methods to Determine Bioavailability
Session Chair: Dr. Isadore Kanfer, Emeritus Professor, Faculty of Pharmacy,
Rhodes University, Grahamstown, South Africa.
Session Co-Chair: Dr. Luis Pereira, Associate Professor,
Pharmacometrics MCPHS, Childrens' Hospital Boston,
Harvard Medical School, Boston, MA, USA.
8:30-8:35 Session Introduction
8:35-9:00 Speech Opportunity Available
9:00-9:25 Speech Opportunity Available
9:25-9:50 Title: Average, Individual and Population Bioequivalence – Understanding the True Variability of a Product
Dr. Bhaswat S. Chakraborty , Sr. Vice President, R&D,
Cadila Pharmaceuticals, India.
9:50-10:15 Title: Bioavailability of  Flavonoids: In Vitro Methods for Assessing Bilitranslocase-Mediated Membrane Transport
Dr. Sabina Passamonti, University of Trieste,
Department of Life Sciences, via L. Giorgieri 1, 34127 Trieste,
Italy.
10:15-10:25 Coffee Break
10:25-10:50 Title: Quantitation of Alpha Amyrin in Scoparia dulcis L. Whole Plant Extract by High Performance Liquid Chromatography
Dr. Kishore Kumar Kadimpati, Dept. Of Plant Sciences,
School of Life Sciences, University of Hyderabad, Gochibowli,
Hyderabad, India.
10:50-11:15 Title: Application of Dermal Microdialysis for the Determination of Bioavailability/Bioequivalence of Topical Drug Products Not Intended for Systemic Circulation
Dr. Isadore Kanfer, Emeritus Professor, Faculty of Pharmacy,
Rhodes University, Grahamstown, South Africa.
11:15-11:40

Title: TBD
Dr. Luis Pereira, Associate Professor,
Pharmacometrics MCPHS, Childrens' Hospital Boston,
Harvard Medical School, Boston, MA, USA.
11:40-12:00 Panel Discussion


Pharmaceutics International, Inc, USA


Division of Product Quality Research, USA


College of Pharmaceutical Sciences, India


Shreemati Nathibai Damodar Thackersey Women's University, India


Maharashtra Institute of Pharmacy, India



March 2, 2010
 (Tuesday)
 13:00-18:00		 Track 2-6: Role of Drug Delivery Systems in Bioequivalence and Bioavailability
Session Chair: Dr. Praveen S. Hiremath, Pharmaceutics Int., Inc., USA.
Session Co-Chair: Dr. Mansoor A. Khan,
Director, Division of Product Quality Research,
FDA/CDER/OPS/OTR, White Oak, LS Building 64,
10903 New Hampshire Ave, Silver Spring, MD, USA.
13:00-13:05 Session Introduction
13:05-13:30 Title: Role of Lipid Based Drug Delivery Systems in Bioavailability Enhancement
Dr. Praveen S. Hiremath, Product Development,
Pharmaceutics International, Inc., 10189 Gilroy Road,
Hunt Valley, MD, USA.
13:30-13:55 Title: TBD
Dr. Mansoor A. Khan,
Director, Division of Product Quality Research,
FDA/CDER/OPS/OTR, White Oak, LS Building 64,
10903 New Hampshire Ave, Silver Spring, MD, USA.
13:55-14:20 Title: Bioavailability and Bioequivalence of Novel Drug Delivery Systems
Dr. N. Udupa, Professor and Principal,
College of Pharmaceutical Sciences, MAHE, Manipal, India.
14:20-14:45 Title: Nanosuspensions for Improved Drug Bioavailability and Targeted Drug Delivery
Prof. Kamalinder.K.Singh,
Principal(Addl. Charge), C.U.Shah College Of Pharmacy,
SNDT Women's University, Santacruz (West),
Mumbai - 400049, India.
14:45-16:20 Coffee Break & Poster Session
16:20-16:45 Title: TBD
Dr. Rajeev Raghuvanshi,
16:45-17:10 Speech Opportunity Available
17:10-17:35 Title: Enhancing Oral Bioavailabilty of Drugs Using Cyclodextrins
Dr. B.S.Kuchekar, Maharashtra Institute of Pharmacy,
MIT Campus, Paud Road, Kothrud, Pune. Maharashtra, India.
17:35-18:00 Panel Discussion
 
Track Infomation
Track 3: BioANAL & BIOANAL Methodology Development and Validation Using HPLC and LCMS


Agilent Technologies India Pvt. Ltd., India


Aizant Drug Research Solutions, India


Central Drug Research Institute, India


University of Athens,
Greece


Jadavpur University,
India
 Time  Track
March 2, 2010
 (Tuesday)
  8:30-12:00 		Track 3-1: Advances in Mass Spectrometry Methodology Development
Session Chair: Dr. Ajit Srivastava
Business Manager - LCMS, Agilent Technologies India Pvt. Ltd,
Plot No 10, Udyog Vihar, Phase IV, Gurgaon – 122016, India.
Session Co-Chair: Dr. S. Ravisankar, PhD, MBA,
Director, Quality Assurance, Clinical Development,
GVK Biosciences Pvt Ltd, India.
8:30-8:35 Session Introduction
8:35-9:00 Title: Recent Developments in BioANAL & BIOANAL Method Validation Requirements for Mass Spectrometric Methods
Dr. S. Ravisankar, PhD, MBA,
Director, Quality Assurance, Clinical Development,
GVK Biosciences Pvt Ltd, India.
9:00-9:25 Title: TBD
Dr. Ajit Srivastava
Business Manager - LCMS, Agilent Technologies India Pvt. Ltd,
Plot No 10, Udyog Vihar, Phase IV, Gurgaon – 122016, India.
9:25-9:50 Title: BioANAL & BIOANAL Method Transfer: Challenges and Recent Developments
Dr.Yarramraju Sitaramaraju, Associate director,
Clinical Development, Aizant Drug Research Solutions P. Ltd.,
Hyderabad, India.
9:50-10:15 Title: Ion Trap as a Tool for In-vitro and In-vivo Metabolite Profiling
Dr. Girish kumar jain,
Head, Division of Pharmacokinetics & Metabolism,
Central Drug Research Institute, Lucknow-226001, India.
10:15-10:25 Coffee Break
10:25-10:50 Speech Opportunity Available
10:50-11:15 Title: BioANAL & BIOANAL Methodology Development and Validation Using HPLC and LCMS-Advances in Mass Spectrometry Methodology Development
Dr. Constantinos Pistos, Lecturer of Toxicology,
Laboratory of Forensic Medicine and Toxicology,
Medical School, University of Athens, Greece.
11:15-11:40 Title: BioANAL & BIOANAL Method Development of the Metabolite 3-desmethylthiocolchicine in Human Plasma by LC-MS/MS
Dr. Sangita Agarwal, Women Scientist-DST,
Dept. of Pharm. Tech., Jadavpur University, Kolkata, India.
11:40-12:00 Panel Discussion


Universiade Federal da Bahia, Brazil


Defence Research and Development, Canada


Cairo University, Egypt


University of Region of Cariri, Brazil


Central Drug Research Institute, India


Tabriz University of Medical Sciences, Iran

 

 

 
March 2, 2010
 (Tuesday)
13:00-18:00		 Track 3-2: Antiviral, Anti Retroviral, Antibacterial and Anti Fungal Drugs  
Session Chair: Call for Host
Session Co-Chair: Call for Co-Host
13:00-13:05 Session Introduction
13:05-13:30 Title: TBD
Dr. Silvia Lima Costa,
Laboratorio de Neuroquimica e Biologia Celular,
Universiade Federal da Bahia, Instituto de Ciências da Saude, Brazil.
13:30-13:55 Title: Protection against Seasonal and Avian Influenza Virus Infections Using Nucleic Acid-Based Antiviral Agents
Dr. Jonathan P. Wong, Defence Scientist,
Defence Research and Development Canada, Suffield,
CP 4000, Succ. Main, Medicine Hat, Alberta, Canada.
13:55-14:20 Title: Biochemical and Biological Studies on Salt Stressed Spirulina Platensis
Dr. Emad A. Shalaby,
Biochemistry Department, Faculty of Agriculture and
Botany Department, Faculty of Science, Cairo University,
Giza, Egypt.
14:20-14:45 Title: The Necessity of New Sinergistic Formulations to Combat the Drug Resistance
Dr. Henrique Douglas Coutinho,
Laboratory of Microbiology and Molecular Biology,
Depart. of Biological Sciences,
University of Region of Cariri - URCA, AV. Cel Antonio Luiz,
Crato (CE), Brazil.
14:45-16:20 Coffee Break & Poster Session
16:20-16:45 Title: Standardization of Herbal Drug Preparations using LC-MS
Dr. Jawahar Lal, Scientist E-II,
Pharmacokinetics & Metabolism Division,
Central Drug Research Institute, CSIR, Lucknow, India.
16:45-17:10 Title: TBD
Dr. Mohammadreza Ghandforoush-Sattari,
Assistant Professor of Clinical Toxicology,
Dept.Pharmacology & Toxicology, Faculty of Pharmacy,
Tabriz University of Medical Sciences, Tabriz, Iran.
17:10-17:35 Speech Opportunity Available
17:35-18:00 Panel Discussion


Hopital Cochin, Paris


Johns Hopkins University, USA


Albert Einstein Medical Center, USA


Yeditepe University, Turkey
March 2, 2010
 (Tuesday)
8:30-12:00		 Track 3-3: Drugs Acting on Central Nervous Systems  
Session Chair: Call for Host
Session Co-Chair: Dr. Raphael Serreau, MD, Responsable Appel d'Offre - PV,
URC Paris Necker-Cochin- EA 3620, Hopital Cochin, Paris.
8:30-8:35 Session Introduction
8:35-9:00 Title: Bioequivalence of generic antiepilepsy drugs
Dr. Gregory Krauss, MD, Professor of Neurology,
Johns Hopkins University, Baltimore, MD, USA.
9:00-9:25 Speech Opportunity Available
9:25-9:50 Title: Codeine and Breastfeeding, What are the Latest Data in Pharmacovigilance and EMEA Regulation
Dr. Raphael Serreau, MD, Responsable Appel d'Offre - PV,
URC Paris Necker-Cochin- EA 3620, Hopital Cochin, Paris.
9:50-10:15 Title: TBD
Dr. S. Chattopadhyay
10:15-10:25 Coffee Break
10:25-10:50 Speech Opportunity Available
10:50-11:15 Title: TBD
Dr. Darshak Karia, MD, Director, Heart Failure Services,
Einstein Heart and Vascular Institute, Levy 3 East,
Albert Einstein Medical Center, Philadelphia, USA.
11:15-11:40 Title: Clinical Study of the Bioequivalence of Trimetazidine Immediate Release and Modified Release Tablets
Dr. Dilek Erol, Yeditepe University, Faculty of Pharmacy, 34755 Kayısdagı, Istanbul, Turkey.
11:40-12:00 Panel Discussion


University of Hyderabad,
India


Boys Town National Research Hospital, USA


V.L. College of Pharmacy, India


University of Wisconsin-Whitewater, USA


University of Nebraska Medical Center, USA


Creighton University Medical Center, USA


Osmania University, India

 
March 2, 2010
 (Tuesday)
13:00-18:00		 Track 3-4: Anticancer/Anti-Neovascular Drugs
Session Chair: Prof. P. Reddanna,
Eicosanoids, Inflammation & Cancer Research Group,
School of Life Sciences, University of Hyderabad, Hyderabad, India.
Session Co-Chair: Dr. Sudhakar Akulapalli, Creighton University Medical Center and University of Nebraska Medical Center.
Director & Coordinator: Cell Signaling and Tumor Angiogenesis Laboratory, Boys Town National Research Hospital, Omaha, USA.
13:00-13:05 Session Introduction
13:05-13:30 Title: Design of New Drug Molecules to be Used in Reversing Multidrug Resistance in Cancer Cells
Prof. Mayur Yergeri, Department of Medicinal Chemistry,
V.L. College of Pharmacy, Raichur, India.
13:30-13:55 Title: Signaling Mechanisms of Endogenous Anti-cancer Molecules Derived From Extra Cellular Matrix Type IV Collagen
Dr. Sudhakar Akulapalli, Creighton University Medical Center and University of Nebraska Medical Center.
Director & Coordinator: Cell Signaling and Tumor Angiogenesis Laboratory, Boys Town National Research Hospital, Omaha, USA.
13:55-14:20 Title: Expanding Applications for Use of Biologically Modified Nanoparticles in Cancer Research
Dr. Eric Michael Bratsolias Brown, Assistant Professor,
Department of Biological Sciences,
University of Wisconsin-Whitewater, Upham Hall,
800 W. Main St., Whitewater, WI 53190, USA.
14:20-14:45 Title: Imatinib Resistance in Chronic Myeloid Leukemia:
Role of COX-2, MDR-1 and HDACs
Prof. P. Reddanna,
Eicosanoids, Inflammation & Cancer Research Group,
School of Life Sciences, University of Hyderabad, Hyderabad, India.
14:45-16:20 Coffee Break & Poster Session
16:20-16:45 Title: Phosphorylation of eIF2α-Mediated Signalling Pathways in Cell Survival and Suicide
Prof. Kolluru VA Ramaiah, Dept of Biochemistry,
School of Life Sciences, University of Hyderabad
Hyderabad, India.
16:45-17:10 Title: Differential Regulation of HIF-1α under Normoxic and Hypoxic Conditions 
Dr. Surya S. Singh, Dept. of Biochemistry,
Osmania University, Hyderabad, India.
17:10-17:35 Speech Opportunity Available
17:35-18:00 Panel Discussion
 
Track Infomation
Track 4: IP, Regulatory Affairs and Outsourcing Alliance


University of Pisa, Italy


KLE University, India


March 2, 2010
 (Tuesday)
13:00-18:00		 Track 4-1: ICH/FDA Guidelines and Regulatory Updates   
Session Chair: Prof. Mario Giorgi, Pharmacology & Toxicology Section,
University of Pisa, V.le delle Piagge 2, 56124 Pisa, Italy.
Session Co-Chair: Prof. Basavaraj K. Nanjwade, Department of Pharmaceutics,
JN Medical college, KLE University, Belgaum- 590010,
Karnataka, India.
13:00-13:05 Session Introduction
13:05-13:30 Speech Opportunity Available
13:30-13:55 Title: PK-PD integration/modeling of NSAID in Veterinary Pharmacology
Prof. Mario Giorgi, Pharmacology & Toxicology Section,
University of Pisa, V.le delle Piagge 2, 56124 Pisa, Italy.
13:55-14:20 Speech Opportunity Available
14:20-14:45 Speech Opportunity Available
14:45-16:20 Coffee Break & Poster Session
16:20-16:45 Title: Regulatory Requirements for Orphan Drugs Delivery
Prof. Basavaraj K. Nanjwade, Department of Pharmaceutics,
JN Medical college, KLE University, Belgaum- 590010,
Karnataka, India.
16:45-17:10 Speech Opportunity Available
17:10-17:35 Speech Opportunity Available
17:35-18:00 Panel Discussion


Clinical Research and Biosciences division, India


Raptakos, Brett & Co. Ltd., India


PharMantra Consulting Solutions, India


The Islamia University of Bahawalpur, Pakistan
March 2, 2010
 (Tuesday)
13:00-18:00		 Track 4-2: Perspectives of Regulatory Agencies, Worldwide, on Bioequivalence Testing
Session Chair: Ms. Neerja S, Dy. Manager, QA, RA Chem Pharma Ltd,
Clinical Research and Biosciences division,
C3 (A) HUDA complex, Tarnaka, Hyderabad, India.
Session Co-Chair: Dr. Pralhad Tayade, DGM Contract Research,
Raptakos Brett & Co., Mumbai, India.
13:00-13:05 Session Introduction
13:05-13:30 Title: Assuring Bioequivalence: Pilot Studies or Dissolution?
Dr. Ranjani Nellore, RAC, PharMantra Consulting Solutions,
Hyderabad, India.
13:30-13:55 Title: Challenges for Preparation of Module 2 & 5 for BA/ BE for US & EMEA
Ms. Neerja S, Dy. Manager, QA, RA Chem Pharma Ltd,
Clinical Research and Biosciences division,
C3 (A) HUDA complex, Tarnaka, Hyderabad, India.
13:55-14:20 Speech Opportunity Available
14:20-14:45 Title: What Should be Indian Pharma R&D’s Focus Areas in 2010
Dr. Pralhad Tayade, DGM Contract Research,
Raptakos Brett & Co., Mumbai, India.
14:45-16:20 Coffee Break & Poster Session
16:20-16:45 Speech Opportunity Available
16:45-17:10 Title: In-Vitro Release and Pharmacokinetics of Anti-tubercle
Drug Ethionamide in Healthy Male Subjects
Prof. Mahmaood Ahmad,
Dean, Faculty of Pharmacy and Alternative Medicine,
The Islamia University of Bahawalpur, Punjab, Pakistan.
17:10-17:35 Speech Opportunity Available
17:35-18:00 Panel Discussion
 
Track Infomation
Track 5: Toxicology

Fundacao Oswaldo Cruz, Brazil


University of Liverpool, UK


Indian Institute of Toxicology Research, India


Institute of Chemical Technology, India


University of California, USA



 Time  Track
March 3, 2010
 (Wednesday)
8:30-12:00 		Track 5-1: Biomarkers in Toxicology
Session Chair: Dr. Rita Mattos, Senior Researcher,
National School of Public Health, Fundacao Oswaldo Cruz,
Ministry of Health, Brazil.
Session Co-Chair: Dr. Dominic Williams, MRC Centre for Drug Safety Science,
Dept. Pharmacology & Therapeutics, Sherrington Building,
The University of Liverpool, Liverpool, UK.
8:30-8:35 Session Introduction
8:35-9:00 Title: TBD
Dr. Kar Chowdhuri, Scientist F and Deputy Director, Embryotoxicology Lab, Indian Institute of Toxicology Research,
P.O. Box No. 80, Mahatma Gandhi Marg, Lucknow 226 001,
Uttar Pradesh, India.
8:35-9:00 Title: Advances and Strategies in Using Biomarkers in Children Lead Exposure
Dr. Rita Mattos, Senior Researcher,
National School of Public Health, Fundacao Oswaldo Cruz,
Ministry of Health, Brazil.
9:25-9:50 Title: TBD
Dr. Maibach  Howard, Dermatology, 
University of California, Sanfransisco, CA, USA.
9:50-10:15 Speech Opportunity Available
10:15-10:25 Coffee Break
10:25-10:50 Title: Biomarkers of Drug-Induced Liver Injury
Dr. Dominic Williams, MRC Centre for Drug Safety Science,
Dept. Pharmacology & Therapeutics, Sherrington Building,
The University of Liverpool, Liverpool, UK.
10:50-11:15 Speech Opportunity Available
11:15-11:40 Title: Biomarkers in Neurotoxicity
Dr. Sadhana Sathaye, Reader in Pharmacy,
Dept. of Pharm. Sci. and Tech.,
Institute of Chemical Technology,
Matunga, Mumbai, India.
11:40-12:00 Panel Discussion


Bio-Acoustic-MEMS in Medicine Laboratory, USA


Synthon BV,
The Netherlands


Research Center for Pharmaceutical Nanotechnology, Iran

March 3, 2010
 (Wednesday)
13:00-18:00		 Track 5-2: Toxicogenomics & Metabolomics
Session Chair: Call for Host
Session Co-Chair: Dr. Utkan Demirci,
Bio-Acoustic-MEMS in Medicine (BAMM)Laboratory,
Center for Bioengineering, Department of Medicine,
Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.
13:00-13:05 Session Introduction
13:05-13:30 Title: TBD
Dr. Utkan Demirci,
Bio-Acoustic-MEMS in Medicine (BAMM)Laboratory,
Center for Bioengineering, Department of Medicine,
Brigham and Women’s Hospital, Harvard Medical School,
Boston, MA, USA.
13:30-13:55 Speech Opportunity Available
13:55-14:20 Title: TBD
Dr. Sandra van Os, Project Leader Clinical R&D, Synthon BV,
Microweg 22, 6503 GN Nijmegen, The Netherlands.
14:20-14:45 Speech Opportunity Available
14:45-16:20 Coffee Break & Poster Session
16:20-16:45 Title: Nonviral Cationic Gene Delivery Nanosystems: Geno compatibility and Toxicogenomics Dilemma
Dr. Y. Omidi, Associate Professor, Faculty of Pharmacy,
Director, Research Center for Pharmaceutical Nanotechnology,
Dean, School of Advanced Biomedical Sciences,
Tabriz University of Medical Sciences, Tabriz, Iran.
16:45-17:10 Speech Opportunity Available
17:10-17:35 Speech Opportunity Available
17:35-18:00 Panel Discussion


Al-Qassim University,
Saudi Arabia


University of Madras, India


SRM University, India


University of Peradeniya,
Sri Lanka


National Institute for Research in Reproductive Health, India

March 3, 2010
 (Wednesday)
 8:30-12:00		 Track 5-3: Environmental Toxicology  
Session Chair: Call for Host
Session Co-Chair: Dr. Sivakumar Gowder, Associate Professor,
Dept. Pharmacology & Biochemistry, Al-Qassim University,
College of Pharmacy, Buraidah, Saudi Arabia.
8:30-8:35 Session Introduction
8:35-9:00 Speech Opportunity Available
9:00-9:25 Title: Effect of Antioxidants on PCB Induced Changes in Male Reproduction
Dr. Arunakaran J, Department of Endocrinology,
Dr. ALM PGIBMS, University of Madras, Chennai, India.
9:25-9:50 Title: Composite Ion Exchange Materials and their Applications to Remove Toxic Metal Ions
Dr. MU. Naushad, SRM University, NCR Campus,
Modinagar, India.
9:50-10:15 Title: Kidney, the Major Organ in the Body to Evaluate Toxic and Transport Properties of Environmental Chemicals
Dr. Sivakumar Gowder, Associate Professor,
Dept. Pharmacology & Biochemistry, Al-Qassim University,
College of Pharmacy, Buraidah, Saudi Arabia.
10:15-10:25 Coffee Break
10:25-10:50 Title: Impact of Melatonin on PCB Induced Neurotoxicity
Dr. P. Venkataraman. Assistant Professor,
Department of Medical Research,
SRM Medical College Hospital and Research Centre,
SRM University, Kattankulathur - 603 203. India.
10:50-11:15 Title: Attitude and Knowledge of Nonsmokers about Secondhand Smoke and their Opinion towards Cessation of Smoking in Malaysia – Findings from International Tobacco Control (ITC) Survey Malaysia
Dr. Mohamed Shukry Zawahir,
South Asian Clinical Toxicology Research Collaboration,
Faculty of Medicine, University of Peradeniya, Peradeniya,
Sri Lanka.
11:15-11:40 Title: Exposure to Bisphenol A, an Environmental Estrogen on Reproductive Health
Dr. Geeta Vanage,
National Center for Preclinical Reproductive and Genetic Toxicology, National Institute for Research in Reproductive Health (ICMR),
JM Street, Parel, Mumbai 400 012, Maharashtra, India.
11:40-12:00 Panel Discussion


Indian Institute of Chemical Technology, India


Centre for Cellular and Molecular Biology, India


Yokohama City University, Japan


Children's Hospital Medical Center, USA


Philip Morris International


Radboud University Nijmegen Medical Center, The Netherlands
March 3, 2010
 (Wednesday)
 13:00-18:00		 Track 5-4: Molecular Epidemiology  
Session Chair: Dr. U. S. N Murthy, Director Grade Scientist/Scientist G,
Head Biology Division,
Indian Institute of Chemical Technology (CSIR),
Ministry of Science and Technology Govt India,
Tarnaka, Hyderabad, India.
Session Co-Chair: Dr. M.V Jagannadham,
Scientist, Centre for Cellular and Molecular Biology,
Tarnaka, Hyderabad -500 007, India.
13:00-13:05 Session Introduction
13:05-13:30 Speech Opportunity Available
13:30-13:55 Title: TBD
Dr. Yoshihiro Ishikawa, Dean, Graduate School of Medicine,
Professor and President, Cardiovascular Research Institute,
Yokohama City University, Graduate School of Medicine, Japan.
13:55-14:20 Title: TBD
Prof. Michael V. Miles, Clinical Pediatrics and Neurology,
Div. of Pathology & Laboratory Medicine,
Children's Hospital Medical Center, 3333 Burnet Ave.,
Cincinnati, OH 45229, USA.
14:20-14:45 Titel: Cigarette Smoke Inhalation Study for Lung Tumorigenicity in A/J Mice
Dr. Rosemarie B. Lichtner,
Philip Morris Research Laboratories GmbH, Germany.
14:45-16:20 Coffee Break & Poster Session
16:20-16:45 Title: TBD
Prof. Thamar Stollman, Department of Surgery,
Radboud University Nijmegen Medical Center, Nijmegen,
The Netherlands.
16:45-17:10 Title: Artificial Intelligence : A Magic Bullet for Epidemiological Studies of Vector Borne Diseases
Dr. U.S.N Murthy, Director Grade Scientist/Scientist G,
Head Biology Division,
Indian Institute of Chemical Technology (CSIR),
Ministry of Science and Technology Govt India,
Tarnaka, Hyderabad, India.
17:10-17:35 Title: The Proteome of the Outer Membrane Vesicles of an Antarctic Bacterium Pseudomonas Syringae
Dr. M.V Jagannadham,
Scientist, Centre for Cellular and Molecular Biology,
Tarnaka, Hyderabad, India.
17:35-18:00 Panel Discussion
 
Track Infomation
Track 6: PK/PD and Drug Discovery


Shandong University School Of  Medicine, China


Aizant Drug Research Solutions, India


Piramal Life Sciences, India


Meerut Institute of Engineering and Technology, India


Florida A & M University, USA


Indian Institute of Technology, India
 Time  Track
March 3, 2010
 (Wednesday)
8:30-12:00 		Track 6-1: Anticancer, Antiviral Drug Development
Session Chair: Dr. Harish Joshi, Laboratory of Drug Discovery,
Design and Research, Department of Cell Biology,
Suite 455 Whitehead Bld., WBRB, 615 Michael Street,
Atlanta, GA-30322, USA.
Session Co-Chair: Dr. Guo Rui Chen, Institute of Clinical Pharmacology,
Qilu Hospital of Shandong University, Jinan, Shandong, China.
8:30-8:35 Session Introduction
8:35-9:00 Title: Challenges in siRNA/shRNA Delivery and Development of RNAi Therapeutics for Cancer
Dr. Tathagata Dutta, Deputy Director,
Formulation Development and Drug Discovery Research,
Aizant Drug Research Solutions,
Hyderabad, India.
9:00-9:25 Title: Pharmacokinetics, Metabolism and Tissue Distribution of Norcantharidin in Human Body, Studied by HPLC-MS/MS and Isotope-labeled Methods
Dr. Guo Rui Chen, Institute of Clinical Pharmacology,
Qilu Hospital of Shandong University, Jinan, Shandong, China.
9:25-9:50 Title: Recent Advances in Anticancer Drug Discovery: Multiple Target Approach to Tackle Tough Tumors
Dr. Sanjay Kumar, Group Leader,
Department of Medicinal Chemistry, Piramal Life Sciences,
Nirlon Complex, Off Western Express Highway, Goregaon (E),
Mumbai 400 063, India.
9:50-10:15 Title: Quantitative Structure-Activity Relationship Studies on Anti-Hepatitis Viral Agents
Dr. S.P.Gupta, Departemt of Pharmaceutical Technology,
Meerut Institute of Engineering and Technology, Meerut, India.
10:15-10:25 Coffee Break
10:25-10:50 Title: Targetted therapy for Treatment of Lung Cancer
Dr. Mandip Singh Sachdeva, Professor and section Leader, Pharmaceutics, Florida A & M University, College of Pharmacy,
Editor in Chief, CRC Critical Reviews in Therapeutic Drug Carrier Systems, Tallahassee, Florida, USA.
10:50-11:15 Title: Hopeful Trip from Herbs to Humans
Dr. Harish Joshi, Laboratory of Drug Discovery,
Design and Research, Department of Cell Biology,
Suite 455 Whitehead Bld., WBRB, 615 Michael Street,
Atlanta, GA-30322, USA.
11:15-11:40 Title: Nano-drug Deliverysystem Particularly for Anti-cancer Drug
Prof P.Pramanik, nano-materials laboratory,
Chemistry Department, Indian Institute of Technology,
Kharagpur, 721302 , India.
11:40-12:00 Panel Discussion

University at Buffalo, USA


Ludwig-Maximilians University, Germany


University of Alberta, Canada


Indian Institute of Chemical Technology, India


Guru Jambheshwar University of Science and Technology, India
March 3, 2010
 (Wednesday)
13:00-18:00		 Track 6-2: Molecular Drug Targets and Fragment based Drug Design
Session Chair: Dr. Wojciech Krzyzanski, Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14260, USA.
Session Co-Chair: Dr. Nazaré Soeiro
13:00-13:05 Session Introduction
13:05-13:30 Title: Assessment of Exposure to Carcinogens: Correlation of Surrogate Biomarkers with Adducts in Target Tissues
Dr. Franky Richter, Walther Straub Institute,
Department of Toxicology, Ludwig-Maximilians University, Germany.
13:30-13:55 Speech Opportunity Available
13:55-14:20 Title: Minimal Effective Concentration and Efficacy of Epoetins
Dr. Wojciech Krzyzanski, Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14260, USA.
14:20-14:45 Title: TBD
Dr. Fakhreddin Jamali,
Faculty of Pharmacy & Pharmaceutical Sciences,
University of Alberta, Edmonton, Alberta, Canada.
14:45-16:20 Coffee Break & Poster Session
16:20-16:45 Title: TBD
Dr. Nazaré Soeiro
16:45-17:10 Title: Biophotonics: Application towards Modern Drug Discovery
Dr. Srinivas kantevari, Sr. Scientist,
Organic Chemistry Division-II,
Indian Institute of Chemical Technology,
Hyderabad, India.
17:10-17:35 Title: Molecular Drug Targets for Development of Antidepressant Drugs
Dr. Dinesh Dhingra, Assistant Professor,
Pharmacology Division,
Department of Pharmaceutical Sciences,
Guru Jambheshwar University of Science and Technology,
Hisar-125001-Haryana, India.
17:35-18:00 Panel Discussion


Kuwait University, Kuwait


Panjab University, India


Monash Institute of Pharmaceutical Sciences, Australia


AstraZeneca R&D Mölndal, Sweden

University of British Columbia, Canada


Rashtrasant Tukadoji Maharaj Nagpur University, India

March 3, 2010
 (Wednesday)
8:30-12:00		 Track 6-3: Improving ADME/DMPK Profile
Session Chair: Dr. Aly Nada, Assoc.Professor & Chairman,
Department of Pharmaceutics, Faculty of Pharmacy,
Kuwait University, POB 24923 Safat, 13110 Kuwait.
Session Co-Chair: Prof. Bhupinder Singh Bhoop,
Pharmaceutics & Pharmacokinetics,
Univ Inst Pharm Sci (UGC Center of Adv Studies),
Dean (Alumni Relations), Panjab University, Chandigarh, India.
8:30-8:35 Session Introduction
8:35-9:00 Title: TBD
Dr. Jian Li, 
Facility for Anti-infective Drug Development and Innovation,
Drug Delivery, Disposition and Dynamics,
Monash Institute of Pharmaceutical Sciences,
Monash University, Australia.
9:00-9:25 Title: TBD
Dr. Hong Wan,
Lead Generation DMPK and Physical Chemistry,
AstraZeneca R&D Mölndal, Sweden.
9:25-9:50 Title: Stability and Rat Skin Permeation of Vitamin E and Vitamin E Acetate in Cosmetic Preparations
Dr. Aly Nada, Assoc.Professor & Chairman,
Department of Pharmaceutics, Faculty of Pharmacy,
Kuwait University, POB 24923 Safat, 13110 Kuwait.
9:50-10:15 Title: TBD
Dr. William Jia, Department of Surgery, Faculty of Medicine,
University of British Columbia, Brain Research Centre, Canada.
10:15-10:25 Coffee Break
10:25-10:50 Title: Enhancing Oral Bioavailability of Drugs using Self-Emulsifying Drug Delivery Systems
Prof. Bhupinder Singh Bhoop,
Pharmaceutics & Pharmacokinetics,
Univ Inst Pharm Sci (UGC Center of Adv Studies),
Dean (Alumni Relations), Panjab University, Chandigarh, India.
10:50-11:15 Title: Pharmacokinetic Significance of Diabetes-induced Changes in CYP3A Activity
Prof. S. N. Umathe, Head of Pharmacology Division,
Department of Pharmaceutical Sciences,
Rashtrasant Tukadoji Maharaj Nagpur University,
Mahatma Jyotiba Fuley Shaikshanik Parisar,
Amravati Road , Nagpur, India.
11:15-11:40 Speech Opportunity Available
11:40-12:00 Panel Discussion


Mayo Clinic School of Medicine, USA


Institut Supérieur de Biotechnologies de Sfax, Tunisie


Vaagdevi college of Pharmacy, India

March 3, 2010
 (Wednesday)
 13:00-18:00		 Track 6-4: PK/PD and Bioanalysis Outsourcing Alliance
Session Chair: Prof. Debabrata Mukhopadhyay,
Department of Biochemistry and Molecular Biology,
Mayo Clinic School of Medicine, Guggenheim 1401A,
200 First Street Southwest, Rochester, MN 55905, USA.
Session Co-Chair: Dr. Anupama Ramkumar, Director, Arkus CTSS, Ahmedabad, India.
13:00-13:05 Session Introduction
13:05-13:30 Speech Opportunity Available
13:30-13:55 Title: More than a Co-receptor: New Perspectives of Neuropilin-1 Function in Endothelium and Tumor Cells
Prof. Debabrata Mukhopadhyay,
Department of Biochemistry and Molecular Biology,
Mayo Clinic School of Medicine, Guggenheim 1401A,
200 First Street Southwest, Rochester, MN 55905, USA.
13:55-14:20 Title: TBD
Dr. Sofiane Bezzine,
Institut Supérieur de Biotechnologies de Sfax,
Route de Soukra km 4, Sfax 3038, Tunisie.
14:20-14:45 Title: TBD
Dr. S. Tamilvanan
14:45-16:20 Coffee Break & Poster Session
16:20-16:45 Title: Bioequivalence Studies for Generics in Patients - Trials or Tribulations?
Dr. Anupama Ramkumar,
Director, Arkus CTSS, Ahmedabad, India.
16:45-17:10 Title: Local Antibiotic Delivery Systems for the Treatment of Osteomyelitis, the Use of Fibrin Clot as a Carrier- an In Vitro and In Vivo Pharmacokinetic Study
Dr. Stefanos Tsourvakas, Orthopaedic Department,
General Hospital of Trikala, Greece.
17:10-17:35 Title: Pharmacokinetic Study of Hair Dye Poisoning: A Study of 50 cases
Dr. M. Nagulu, Department of Clinical Pharmacy Services,
M.G.M Hospital, Vaagdevi college of Pharmacy, Warangal, India.
17:35-18:00 Panel Discussion


Central Drug Research Institute, India


Sun Pharma, India



Jahaharlal Nehru Technological University, India


Satara College of Pharmacy, India

March 3, 2010
 (Wednesday)
 13:00-18:00		 Track 6-5: Road Map to Drug Discovery and Develoment
Session Chair: Dr. Girish kumar jain,
Head, Division of Pharmacokinetics & Metabolism,
Central Drug Research Institute, Lucknow-226001, India.
Session Co-Chair: Dr. Sanjay Mandhane, Pharmacology Division,
Sun Pharma Advanced Research Company Limited,
Atladara, Tandalja Road, Vadodara, Gujarat 390 020, India.
13:00-13:05 Session Introduction
13:05-13:30 Title: Is Natural Product Domain a Good Hunting Hub in the Navigation of Drug Like and Drug Molecules?
Dr. A. Jayashree, Scientist, Jahaharlal Nehru Technological University, Hyderabad, India.
13:30-13:55 Speech Opportunity Available
13:55-14:20 Title: Materials and Methods for Innovation-Are We Ready for Drug Discovery?
Dr. Sanjay Mandhane, Pharmacology Division,
Sun Pharma Advanced Research Company Limited,
Atladara, Tandalja Road, Vadodara, Gujarat 390 020, India.
14:20-14:45 Speech Opportunity Available
14:45-16:20 Coffee Break & Poster Session
16:20-16:45 Title: Therapeutic Alternatives from Venoms and Toxins : Drug Challenges of the Future
Prof. Shivaji P.Gawade,
Professor in Pharmacology and Principal,
Satara College of Pharmacy, Plot 1539,
New Additional MIDC, Behind Spicer India Ltd,
Degaon, Satara, M.S., India.
16:45-17:10 Title: Human Membrane Guanylate Cyclases: Understanding the Structural Basis of Receptor-Ligand Interactions and Approaches to Drug Design
Prof. Paul Roesch, Research Center for Bio-Macromolecules,
U. of Bayreuth 95440 Bayreuth, Germany.
17:10-17:35 Speech Opportunity Available
17:35-18:00 Panel Discussion
 
Track Infomation
Track 7: Bioavailability


All India Institute of Medical Sciences, India


Govt. College of Pharmacy, India



 
 Time  Track
March 3, 2010
 (Wednesday)
 8:30-12:00 		Track 7-1: Influence of Disease on Bioavailability
Session Chair: Call for Host
Session Co-Chair: Dr. Thirumurthy velpandian,
Associate Professor & In-Charge,
Department of Ocular Pharmacology & Pharmacy,
Dr.Rajendra Prasad Centre for Ophthalmic Sciences,
All India Institute of Medical Sciences, New Delhi, India.
8:30-8:35 Session Introduction
8:35-9:00 Title: Liver Diseses Affecting Bioavailability
Dr. Dibya Sundar Panda, Institute of Pharmacy and Technology, Salipur-754202, Cuttack, India.
9:00-9:25 Speech Opportunity Available
9:25-9:50 Title: Pros and Cons of Ocular bio-availability of Drugs
Dr. Thirumurthy velpandian,
Associate Professor & In-Charge,
Department of Ocular Pharmacology & Pharmacy,
Dr.Rajendra Prasad Centre for Ophthalmic Sciences,
All India Institute of Medical Sciences, New Delhi, India.
9:50-10:15 Speech Opportunity Available
10:15-10:25 Coffee Break
10:25-10:50 Title: TBD
Dr. Motte Laurence, Université Paris, Nanomaterials group,
CSPBAT Laboratory, France.
10:50-11:15 Title: Are Bioavailability Studies Warranted in Specific Disease States?
Dr. S.B. Bhise, Principal, Govt. College of Pharmacy,
Karad, India.
11:15-11:40 Speech Opportunity Available
11:40-12:00 Panel Discussion


Andhra University, India


Novartis, USA


University Children's Hospital Basel, Switzerland


University of Kentucky School of Medicine, USA


Huashan hospital of Fudan University, China


Jagiellonian University


Royal College of Surgeons in Ireland, Ireland
March 3, 2010
 (Wednesday)
13:00-18:00		 Track 7-2: Factors Influencing Bioavailability and Bioequivalence
Session Chair: Prof. T. Satyanarayana,
Principal, College of Pharmaceutical Sciences,
Andhra University, Visakhapatnam, India.
Session Co-Chair: Dr. Tycho Heimbach,
Novartis Institutes for BioMedical Research,
DMPK - Translational Sciences (TS), USEH, 436/3253,
One Health Plaza, East Hanover, NJ 07936-1080, USA.
13:00-13:05 Session Introduction
13:05-13:30 Title: Immunomodulation by Biologic Intravenous Immunoglobulins IVIG: Immune Thrombocytopenia ITP as a Model for the last 30 Years
Dr. Paul Imbach, University Children's Hospital Basel UKBB, Basel, Switzerland.
13:30-13:55 Title: The Bioavailability of Heparin-binding Molecules on Vascular Walls is Regulated by Heparan Sulfate and Flow Rate
Dr. Michael Fannon,
University of Kentucky School of Medicine,
Lexington, KY, USA.
13:55-14:20 Title: TBD
Dr. Peinan Sun, The Department of Clinical Pharmacology,
Huashan hospital of Fudan University, Shanghai, China.
14:20-14:45 Title: Factors Influencing Bioavailability and Bioequivalence
Prof. Vijaya Ratna, AU College of Pharmaceutical Sciences,
Andhra University, Visakhapatnam, India.
14:45-16:20 Coffee Break & Poster Session
16:20-16:45 Title: Roles of Oral Drug Absorption, Bioavailability and Exposure Prediction in Drug Development
Dr. Tycho Heimbach,
Novartis Institutes for BioMedical Research,
DMPK - Translational Sciences (TS), USEH, 436/3253,
One Health Plaza, East Hanover, NJ 07936-1080, USA.
16:45-17:10 Title: Combining Population-based Mechanistic Modeling of Oral Absorption and Parameter Estimation Algorithms to Obtain Reliable Predictions of Bioavailability
Prof. Sebastian Polak, Jagiellonian Univ, Krakow,
Poland and Simcyp, Poland.
17:10-17:35 Title: Aspirin Resistance: The Role of Poor Bioavailability of Enteric Coated Aspirin
Dr. Dermot Cox, Molecular and Cellular Therapeutics,
Royal College of Surgeons in Ireland,
123 St. Stephens Green, Dublin 2, Ireland.
17:35-18:00 Panel Discussion

KLE University, India


University of Texas at Austin, USA


Saudi Food and Drug Authority, Saudi Arabia


University of Ljubljana, Slovenia
March 3, 2010
 (Wednesday)
 8:30-12:00		 Track 7-3: The Role of Intestinal Metabolism on Bioavailability
Session Chair: Prof. Basavaraj K. Nanjwade, Department of Pharmaceutics,
JN Medical college, KLE University, Belgaum- 590010,
Karnataka, India.
Session Co-Chair: Call for Co-Host
8:30-8:35 Session Introduction
8:35-9:00 Title: Challenges in Establishing Bioequivalence of Complex Modified Release Dosage Forms
Dr. Salomon Stavchansky, Division of Pharmaceutics,
College of Pharmacy, University of Texas at Austin, Austin, Texas, USA.
9:00-9:25 Speech Opportunity Available
9:25-9:50 Title: TBD
Dr. Abdullah Al-Mohizea,
Director of Product Evaluation and Standard Setting Department, Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
9:50-10:15 Title: The Importance of Intestinal Wall Metabolism – the Case of Raloxifene
Dr. Trontelj Jurij, Dept. Biopharmacy and Pharmacokinetics,
Faculty of Pharmacy, University of Ljubljana Askerceva 7, Ljubljana, Slovenia.
10:15-10:25 Coffee Break
10:25-10:50 Title: Enhancing Drug Bioavailability by Overcoming Intestinal Metabolism
Prof. Basavaraj K. Nanjwade, Department of Pharmaceutics,
JN Medical college, KLE University, Belgaum- 590010,
Karnataka, India.
10:50-11:15 Title: Enhancement of Bioavailability of Aceclofenac Using Solid Dispersion Technique
Dr. Sharma V. K, D.J. College of Pharmacy, Modinagar, 201204, UP, India.
11:15-11:40 Speech Opportunity Available
11:40-12:00 Panel Discussion


Cetero Research, USA


Panacea Biotec Ltd., India


Y.B. Chavan College of Pharmacy, India


Panjab University, India


Dibrugarh University, India


M. L. Sukhadia University, India


Dr H S Gour University, India

 
March 3, 2010
 (Wednesday)
  13:00-18:00		 Track 7-4: In Vitro Methods to Determine Bioavailability & In Vitro-In Vivo Correlations
Session Chair: Dr. Sam Raney,
Associate Director, Pre-Clinical Dermatology,
Cetero Research, Adjunct Professor of Pharmaceutical Sciences at North Dakota State University, USA.
Session Co-Chair: Dr. Shivanand Puthli, Drug Delivery Division,
Panacea Biotec Ltd., Navi-Mumbai, Maharashtra, India.
13:00-13:05 Session Introduction
13:05-13:30 Title: Assessing BA/BE of Topical Formulations In Vitro:
In Vitro – In Vivo Correlation Provides a Practical Surrogate to Clinical BE Studies
Dr. Sam Raney, Associate Director, Pre-Clinical Dermatology,
Cetero Research, Adjunct Professor of Pharmaceutical Sciences at North Dakota State University, USA.
13:30-13:55 Title: Understanding the Significance of In-vitro/ In-vivo Correlation in Pharmacokinetic Predictions
Dr. Shivanand Puthli, Drug Delivery Division,
Panacea Biotec Ltd., Navi-Mumbai, Maharashtra, India.
13:55-14:20 Title: In Vitro Methods to Determine Bioavailability & IVIVC of Oral Dosage Forms and Drug Delivery Systems
Dr. Vijay D. Wagh, Associate Professor In Pharmaceutics,
Y.B. Chavan College of Pharmacy, Aurangabad.
and
Editor In Chief, Indian Journal of Pharmaceutics,
Serial Publications, Daria Ganj, New Delhi, India.
14:20-14:45 Title: Endeavoring Biowaivers Using IVIVC: Shifting Paradigms
Prof. Bhupinder Singh Bhoop,
Pharmaceutics & Pharmacokinetics,
Univ Inst Pharm Sci (UGC Center of Adv Studies),
Dean (Alumni Relations), Panjab University, Chandigarh, India.
14:45-16:20 Coffee Break & Poster Session
16:20-16:45 Title: Transdermal Bioavailability of Trazodone Hydrochloride: Invitro-Invivo Correlation
Dr. Malay K. Das, Division of Pharmaceutics,
Department of Pharmaceutical Sciences, Dibrugarh University,
Dibrugarh 786004, India.
16:45-17:10

Title: Effect of Test Parameters on In-vitro Method to Determine Bioavailability of Dosage Forms
Dr. Abhishek kumar Jain, Research Scholar and Lecturer,
Department of Pharmaceutical Science,
M. L. Sukhadia University, Udaipur, Rajasthan, India.
17:10-17:35 Title: TBD
Dr. Avijeet Jain,
Research Scholar, Natural Product Research Laboratory,
Dept of Pharmaceutical Sciences, Dr H S Gour University,
Sagar, MP, India.
17:35-18:00 Panel Discussion
 
Participants List
(Academia)
University of Notre Dame, USA

Faculty of Medicine Siriraj Mahidol University, Thailand

Nova Southeastern University, USA

The Australian National University Medical School, University of Canberra, Australia

University of Hyderabad, India

Panjab University, Chandigarh, India

Institute of Biotechnology and Antibiotics, Warsaw, Poland

Texas Tech School of Pharmacy, USA

University of Petra, Jordan

Jadavpur University, India

University of British Columbia, Canada

Canadian Society for Pharmaceutical Sciences, Canada

National University of Singapore, Singapore

King Saud University, Saudi Arabia

Widener University, USA

Stanford University School of Medicine, USA

University at Buffalo, State University of New York, USA

School of Biological Sciences, University of Edinburgh, UK

Chungnam National University, Korea

Harvard Medical School, USA

Polish Academy of Sciences, Poland

University of Trieste, Italy

College of Pharmaceutical Sciences, MAHE, India

Medical School, University of Athens, Greece

Universiade Federal da Bahia, Instituto de Ciências da Saude, Brazil

University of Region of Cariri - URCA, Brazil

Tabriz University of Medical Sciences, Iran

Johns Hopkins University, USA

Creighton University Medical Center and University of Nebraska Medical Center, USA

University of Pisa, Italy

The University of Liverpool, UK

The Islamia University of Bahawalpur, Pakistan

University of California, Sanfransisco, USA

Al-Qassim University, College of Pharmacy Buraidah, Saudi Arabia

University of Madras, India

SRM University NCR Campus, India

University of Peradeniya, Sri Lanka

Yokohama City University, Graduate School of Medicine, Japan

Radboud University Nijmegen Medical Center, The Netherlands

Qilu Hospital of Shandong University, China

Meerut Institute of Engineering and Technology, India

Florida A & M University, College of Pharmacy, USA

Jawaharlal Nehru Technological University, India

Ludwig-Maximilians University, Germany

V.L. College of Pharmacy, India

University of Alberta, Canada

Panjab University, India

Monash Institute of Pharmaceutical Sciences, Monash University, Australia

University of British Columbia, Brain Research Centre, Canada

Univ Inst Pharm Sci (UGC Center of Adv Studies), Panjab University, India

Institut Supérieur de Biotechnologies de Sfax, Tunisie

All India Institute of Medical Sciences, India

Rhodes University, South Africa

Université Paris, France

Faculty of Pharmacy, University of Ljubljana Askerceva 7, Slovenia

Chungnam National University, Korea

Dr H S Gour University, India

National School of Public Health, Ministry of Health, Brazil

University of Toronto, Canada

Oncology Institute of Vojvodina , Serbia

Indian Institute of Chemical Technology, India

Indian Institute of Toxicology Research, India

Einstein Heart and Vascular Institute, Albert Einstein Medical Center, USA

University of Texas at Austin, USA

National Institute for Research in Reproductive Health (ICMR), India

National Cancer Institute, USA

Participants List
(Business)
US Pharmacopeia, USA

Food and Drug Administration, USA

University Hospital Zurich, Switzerland

B. V. Patel Perd Centre, India

Guy's Hospital, UK

Hôpital Saint-Antoine, Paris

A. Manzoni Hospital, Italy

Kazusa DNA Research Institute, Japan

Pharmaceutics Int., Inc., USA

Agilent Technologies, USA

Central Drug Research Institute, India

EMF Consulting, France

Hopital Cochin, Paris

Boys Town National Research Hospital, Omaha, USA

Aurobindo Pharma Ltd., India

Abbott labs, USA

Synthon BV, The Netherlands

Children's Hospital Medical Center, USA

Piramal Life Sciences, India

AstraZeneca R&D Mölndal, Sweden

Sun Pharma Advanced Research Company Limited, India

Ranbaxy Research Laboratories, India

University Children's Hospital Basel UKBB, Switzerland

Huashan hospital of Fudan University, China

Novartis Institutes for BioMedical Research, USA

Defence Research and Development Canada Suffield, Canada

Saudi Food and Drug Authority, Saudi Arabia

Cetero Research, USA

Panacea Biotec Ltd., India

Lupin Ltd., India
Copyright © 2009 OMICS Publishing Group